the sample was made up of 11 women and 19 men, with an
average age of 68 years (51-87 years). After the chemotherapy treatment, the authors observed
a clinically-relevant improvement in general quality of life, as well as in the symptoms of dyspnea,
insomnia, hemoptysis, cough, thoracic pain, pain in the arm/shoulder, and financial difficulty.
There was a worsening on the functional scale which assesses role performance and symptoms
of fatigue, nausea and vomiting, sensory neuropathy, pain in other parts, constipation, loss of
appetite and alopecia.